Dr. Reddy’s Laboratories Gets EIR From U.S. FDA For Visakhapatnam Units
The company has received EIR from the United States Food and Drug Administration for the inspection conducted at the formulations manufacturing plants at Duvvada, Visakhapatnam, Dr. Reddy's Laboratories said in a regulatory filing.
The inspection of the two facilities were completed by the U.S. FDA on June 21 this year, it added.
"We have now received an EIR from the U.S. FDA, indicating closure of this audit," the company said.
The U.S. FDA gives EIR on closure of inspection of an establishment that is the subject of an U.S. FDA or U.S. FDA-contracted inspection.